Hong Kong Consumer Durables Stock News

SEHK:6868
SEHK:6868Food

Tenfu Cayman Holdings SEHK 6868 Margin Resilience Challenges Long Term Earnings Decline Narrative

Tenfu (Cayman) Holdings (SEHK:6868) has opened FY 2025 with first half revenue of C¥672.9 million and basic EPS of C¥0.045, set against a trailing twelve month line of C¥1.33 billion in revenue and EPS of C¥0.11. The company has seen revenue move from C¥811.3 million with EPS of C¥0.064 in the first half of FY 2024 to C¥751.4 million and EPS of C¥0.064 in the second half of FY 2024, before landing at the current FY 2025 first half run rate. This leaves investors to weigh a 9.2% trailing net...
SEHK:1044
SEHK:1044Personal Products

Hengan International Group (SEHK:1044) Margin Improvement Challenges Long Term Earnings Decline Narrative

Hengan International Group (SEHK:1044) has posted its FY 2025 results with second half revenue of C¥11.3b and basic EPS of C¥1.02, alongside trailing 12 month revenue of C¥23.1b and EPS of C¥2.23. This gives investors a clear read on the latest earnings run rate. The company has seen revenue move from C¥10.8b and EPS of C¥0.78 in the second half of 2024 to C¥11.3b and EPS of C¥1.02 in the second half of 2025. Trailing 12 month net income stands at C¥2.54b, providing context for investors to...
SEHK:2013
SEHK:2013Software

Weimob (SEHK:2013) Loss Narrows To C¥33 Million Challenging Bearish Margin Narratives

Weimob (SEHK:2013) has just posted its FY 2025 first half numbers, with revenue of C¥775.5 million and a basic EPS loss of C¥0.009, while trailing twelve month figures show revenue of C¥1.6 billion and a basic EPS loss of C¥0.06 as the business continues to work through a period of negative earnings. The company has seen revenue range from C¥867.4 million in the first half of 2024 to C¥471.8 million in the second half of 2024 and then to C¥775.5 million in the first half of 2025. Over those...
SEHK:1503
SEHK:1503REITs

China Merchants Commercial REIT (SEHK:1503) Deep Discount Reinforces Bearish Loss‑Focused Narratives

China Merchants Commercial Real Estate Investment Trust (SEHK:1503) has released its FY 2025 numbers with first half revenue at C¥225.0 million and basic EPS of C¥0.04 loss per unit, setting the tone for another period where investors are closely tracking cash generation from the portfolio. The trust has seen reported revenue move from C¥266.3 million in 1H 2024 to C¥263.0 million in 2H 2024 and then C¥225.0 million in 1H 2025, while basic EPS shifted from a C¥0.12 loss in 1H 2024 to a C¥0.04...
SEHK:6969
SEHK:6969Tobacco

Smoore International Holdings (SEHK:6969) Margin Slide Challenges Bullish Growth Narrative After FY 2025 Results

Smoore International Holdings (SEHK:6969) has just reported its FY 2025 numbers, with fourth quarter revenue of about C¥4.0b and net income of C¥254.7m, alongside trailing twelve month revenue of roughly C¥14.3b, net income of C¥1.1b and EPS of C¥0.1744. Over the past year, revenue has moved from C¥11.8b to C¥14.3b while net income shifted from C¥1.3b to C¥1.1b and EPS eased from C¥0.2142 to C¥0.1744. This sets a clear context for how the business is now converting sales into profit. For...
SEHK:1033
SEHK:1033Energy Services

Sinopec Oilfield Service (SEHK:1033) Q4 Loss And 0.8% Margin Test Bullish Growth Narratives

Sinopec Oilfield Service (SEHK:1033) has released its FY 2025 numbers with fourth quarter revenue of about C¥25.5b and a small loss, as Basic EPS slipped to C¥0.000573, compared with C¥25.6b of revenue and Basic EPS of C¥0.002278 in the same quarter a year earlier. Over recent periods the company has seen quarterly revenue move from roughly C¥18.1b in Q3 2024 to C¥18.1b in Q3 2025 and EPS shift from C¥0.012 to C¥0.009076, while trailing twelve month EPS sits at C¥0.035 on revenue of about...
SEHK:775
SEHK:775Biotechs

CK Life Sciences Int'l. (Holdings) (SEHK:775) Loss Deepens Challenging Bullish Narratives

CK Life Sciences Int'l. (Holdings) (SEHK:775) has just reported its FY 2025 first half numbers, with revenue of HK$2,605.8 million and a basic EPS loss of HK$0.0157, while trailing twelve month figures show revenue of HK$5.4 billion and a basic EPS loss of HK$0.0194. Over the recent reported halves, the company has seen revenue move from HK$2,635.9 million in 1H 2024 to HK$2,886.8 million in 2H 2024 and then to HK$2,605.8 million in 1H 2025. This has come alongside a shift in basic EPS from...
SEHK:867
SEHK:867Pharmaceuticals

China Medical System Holdings SEHK 867 Margin Decline Tests Bullish Growth Narrative

China Medical System Holdings (SEHK:867) has put fresh numbers on the table for FY 2025, posting first half revenue of C¥4.0b and basic EPS of C¥0.39, alongside trailing twelve month revenue of C¥7.9b and EPS of C¥0.68. The company has seen revenue move from C¥3.6b in the first half of FY 2024 to C¥4.0b in the first half of FY 2025 and trailing revenue shift from C¥7.5b to C¥7.9b, with basic EPS across reported halves ranging between C¥0.29 and C¥0.39. For you as an investor, the key question...
SEHK:1398
SEHK:1398Banks

A Look At ICBC (SEHK:1398) Valuation As Investors Await Board Meeting On Results And Dividends

Why the upcoming board meeting matters for ICBC shareholders Industrial and Commercial Bank of China (SEHK:1398) has called a board meeting for 27 March 2026 in Beijing to approve its 2025 annual results and review dividend arrangements. This meeting provides an updated view of the bank’s profitability, capital management and potential cash returns. As a result, the stock often comes into focus ahead of such announcements. See our latest analysis for Industrial and Commercial Bank of...
SEHK:934
SEHK:934Oil and Gas

A Look At Sinopec Kantons Holdings (SEHK:934) Valuation After Weaker 2025 Annual Results

Sinopec Kantons Holdings (SEHK:934) released full year 2025 results reporting HK$658.64 million in sales and HK$1,028.26 million in net income, with both sales and earnings per share lower than the prior year. See our latest analysis for Sinopec Kantons Holdings. The earnings release and recent board meeting about dividend considerations have come alongside a 5.42% 90-day share price return and a 5.40% 1-year total shareholder return. The very large 3-year total shareholder return of 88.95%...
SEHK:3360
SEHK:3360Diversified Financial

Far East Horizon (SEHK:3360) Valuation Check After Full Year Earnings And Proposed Dividend

Far East Horizon (SEHK:3360) has come into focus after reporting full year 2025 earnings, along with a proposed final dividend of HK$0.31 per share. This gives investors fresh information on income and shareholder payout. See our latest analysis for Far East Horizon. At a share price of HK$7.29, Far East Horizon has seen a 3.11% 1 day share price return, while the 30 day and year to date share price returns remain negative, even as the 1 year total shareholder return stands at 22.11% and the...
SEHK:9999
SEHK:9999Entertainment

Is It Time To Reassess NetEase (SEHK:9999) After Its Recent Share Price Pullback?

If you are wondering whether NetEase at HK$186.8 is offering good value or not, you are in the right place because this article focuses squarely on what that price might represent. The stock has returned 19.9% over the last year, while the year to date return is an 18.4% decline, with shorter term moves of 0.6% over 30 days and a 0.6% decline over the past week hinting at shifting sentiment. Recent coverage of NetEase has focused on its position as a major Hong Kong listed media name, with...
SEHK:1060
SEHK:1060Entertainment

Assessing Damai Entertainment Holdings (SEHK:1060) Valuation After MAISEAT’s Sold Out Concert Ticketing Win

MAISEAT partnership puts Damai’s ticketing technology in the spotlight Damai Entertainment Holdings (SEHK:1060) is drawing attention after MAISEAT, powered by its ticketing infrastructure, secured its first primary ticketing role for Chinese rapper GAI’s Malaysia concert, with presale tickets already sold out. See our latest analysis for Damai Entertainment Holdings. The MAISEAT win comes at a time when Damai Entertainment Holdings’ share price, now at HK$0.70, has a 1-day share price return...
SEHK:9863
SEHK:9863Auto

Leapmotor (SEHK:9863) Profit Turnaround Tests Bullish Growth Narratives After FY 2025 Earnings

Zhejiang Leapmotor Technology (SEHK:9863) has reported its FY 2025 results with second half revenue of C¥40.5b and basic EPS of C¥0.36, alongside net income of C¥505.4m that extends a trailing twelve month net profit of C¥538.4m and basic EPS of C¥0.39. The company has seen revenue move from C¥23.3b and basic EPS of C¥0.02 in the first half of 2025, from C¥23.3b and a basic EPS loss of C¥0.46 in the second half of 2024. Trailing twelve month figures show revenue at C¥64.7b and a shift from a...
SEHK:2533
SEHK:2533Semiconductor

A Look At Black Sesame International Holding’s Valuation After Strong 2025 Revenue Guidance And Narrowing Losses

Why Black Sesame International Holding’s new guidance matters Black Sesame International Holding (SEHK:2533) has issued fresh 2025 guidance, flagging revenue of over CN¥800 million and narrower losses. This places its advanced driver assistance and robotics businesses firmly in focus for investors. See our latest analysis for Black Sesame International Holding. At a share price of HK$19.04, Black Sesame International Holding has a 1-day share price return of 2.59%. However, the 1-year total...
SEHK:2007
SEHK:2007Real Estate

Country Garden Holdings SEHK 2007 Valuation Check After February 2026 Sales Update

February sales update and why it matters for investors Country Garden Holdings (SEHK:2007) has released preliminary unaudited sales figures for February 2026, reporting contracted sales of approximately RMB 2.23b and contracted sales GFA of about 0.29 million square meters. For you as an investor, this sales and area update offers a fresh data point on how the group is transacting during a challenging period for Chinese real estate, and how its projects are converting into contracted cash...
SEHK:1828
SEHK:1828Insurance

FWD Group Holdings (SEHK:1828) Net Margin Shift To 5.3% Tests High Growth Narrative

FWD Group Holdings (SEHK:1828) has just posted its FY 2025 first half scorecard, with revenue of about US$1.5 billion and basic EPS of US$0.05. This helps set the tone for how investors may interpret the company’s sharp earnings reset over the past year. The company reported revenue of US$1.3 billion in 2H 2024 and US$1.6 billion in 1H 2024 before this latest half, while basic EPS moved from US$0.0032 in 1H 2024 and US$0.0223 in 2H 2024 to US$0.05. This progression puts a clear spotlight on...
SEHK:2386
SEHK:2386Construction

Sinopec Engineering Group (SEHK:2386) Margin Compression Challenges Bullish Earnings Growth Narrative

SINOPEC Engineering (Group) (SEHK:2386) has just posted its FY 2025 numbers with first half revenue of about C¥31.6b and basic EPS of C¥0.32, set against trailing twelve month revenue of roughly C¥70.1b and EPS of C¥0.41 that frame the latest performance. Over recent periods the company has seen revenue move from around C¥28.7b in 1H 2024 to C¥31.6b in 1H 2025, while basic EPS shifted from C¥0.30 in 1H 2024 to C¥0.32 in 1H 2025. This gives investors a clear read on how the top line and EPS...
SEHK:1606
SEHK:1606Diversified Financial

A Look At China Development Bank Financial Leasing’s Valuation After Recent Share Price Moves

Recent share performance and valuation context China Development Bank Financial Leasing (SEHK:1606) has drawn investor attention after a recent 1.4% daily gain, contrasting with a month return of about 4.5% decline and a past 3 months slide of roughly 11.4%. At a last close of HK$1.48 and an estimated intrinsic discount of about 75%, the leasing group, which generates CN¥16,166.205 in revenue and CN¥5,022.752 in net income, now screens as a higher value score name. See our latest analysis for...
SEHK:6963
SEHK:6963Insurance

Sunshine Insurance Group SEHK 6963 EPS Rebound to C¥0.29 Tests Cautious Growth Narratives

Sunshine Insurance Group (SEHK:6963) opened FY 2025 with first half revenue of C¥38.5b and basic EPS of C¥0.29, against trailing 12 month revenue of C¥79.5b and EPS of C¥0.55, setting a clear earnings season marker for investors watching the stock at C¥3.63. Over the past few reporting periods, revenue has moved from C¥38.3b in the first half of 2024 to C¥40.3b in the second half of 2024 and C¥38.5b in the first half of 2025. Basic EPS shifted from C¥0.27 to C¥0.20 and then to C¥0.29, giving...
SEHK:1882
SEHK:1882Machinery

Haitian International Holdings FY 2025 EPS Beat Challenges Cautious Market Narratives

Haitian International Holdings (SEHK:1882) just reported its FY 2025 first half with revenue of C¥9.0b and basic EPS of C¥1.07, setting the tone against a trailing twelve month picture that includes C¥17.7b in revenue and EPS of C¥2.07. The company has seen revenue move from C¥8.0b in the first half of 2024 to C¥9.0b in the first half of 2025, while basic EPS has gone from C¥0.95 to C¥1.07 over the same period, all against a trailing net profit margin of 18.6% that leaves investors focused on...
SEHK:700
SEHK:700Interactive Media and Services

Tencent Holdings (SEHK:700) Valuation Check As AI Agent Push And Gaming Tools Draw Investor Attention

Tencent Holdings (SEHK:700) is back in focus after crowds lined up outside its headquarters to install OpenClaw, while the company also builds its own AI agent for the WeChat superapp. See our latest analysis for Tencent Holdings. Tencent’s HK$550.0 share price comes after a 3.38% 1 month share price return and a weaker 11.72% year to date share price return. The 1 year total shareholder return of 2.55% and 3 year total shareholder return of 64.02% point to stronger performance over a longer...
SEHK:2145
SEHK:2145Personal Products

Should Shanghai Chicmax Cosmetic’s (SEHK:2145) Bullish 2025 Guidance Driven by KANS and newpage Require Action From Investors?

Shanghai Chicmax Cosmetic Co., Ltd. previously issued unaudited guidance for 2025, indicating expected revenue of about RMB 9,100.0 million to RMB 9,200.0 million and profit of roughly RMB 1,140.0 million to RMB 1,160.0 million, both showing strong year-on-year increases versus 2024. The company linked this outlook to the effectiveness of its multi-brand, multi-category approach, highlighting especially strong momentum from its KANS anti-aging skincare line and its infant-focused newpage...
SEHK:2269
SEHK:2269Life Sciences

A Look At WuXi Biologics (SEHK:2269) Valuation After Earendil Deal And Biopharma Excellence Awards

WuXi Biologics (Cayman) (SEHK:2269) is back in focus after two recent developments: a collaboration with Earendil Labs on complex antibody and ADC programs, and a record showing at the 2026 Asia Pacific Biopharma Excellence Awards. See our latest analysis for WuXi Biologics (Cayman). Those Earendil and awards announcements arrive as momentum has been mixed, with a 12.85% 1 month share price return decline, a 90 day share price return of 8.73%, and a 1 year total shareholder return of...